Financials
Income statement
Fiscal date | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
---|---|---|---|---|
Total reported revenue | 2.3T | 2.3T | 2.4T | 2.3T |
Cost of revenue | 1.7T | 1.7T | 2.1T | 1.6T |
Gross profit | 657.5B | 647.3B | 310.8B | 646.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 329.3B | 324.9B | -410.3B | 306.2B |
Operating income | 261.8B | 251.7B | 292.1B | 277.5B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 60.2B | 59.2B | 44.2B | 57.9B |
Other income expense | — | — | — | — |
Pretax income | 250.4B | 232.3B | 278.2B | 259.9B |
Tax provision | 59.4B | 57.9B | 65.8B | 63.5B |
Net income | 193.2B | 174.5B | 212.4B | 196.4B |
Basic EPS | — | 22.4 | — | 25.5 |
Diluted EPS | — | 22.4 | — | 25.5 |
Basic average shares | — | 6.8B | — | 6.8B |
Diluted average shares | — | 6.8B | — | 6.8B |
EBITDA | 310.5B | 291.5B | 322.4B | 317.8B |
Net income from continuing op. | — | — | — | — |
Minority interests | -27.6B | -23.1B | -22.9B | -23.8B |
Preferred stock dividends | 0 | 0 | 0 | 0 |